Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Idexx Laboratories hails solid start to 2015 in first quarter report

Idexx Laboratories hails solid start to 2015 in first quarter report

29th April 2015

Idexx Laboratories has expressed satisfaction with its financial performance for the first quarter of 2015, during which it reported a revenue total of $382 million (247.1 million pounds).

This represented a year-on-year improvement of six percent, with normalised organic revenue growth standing at 11.4 percent, supported by solid growth across business segments.

Its premium instrument placements increased by 24 percent, supported by a 35 percent rise in Catalyst placements, while it achieved 14 percent normalised organic growth in CAG Diagnostics recurring revenues, supported by strong gains in instrument consumables and reference lab sales.

The firm has also revised its full-year financial outlook to reflect the continued strengthening of the US dollar, while adjusting its normalised organic revenue growth outlook by 1.5 percentage points to a new range of 12 to 13 percent.

Jonathan Ayers, the company's chairman and chief executive officer, said: "Expansion of our commercial capability globally drove very strong instrument placements across US and international markets, supporting continued expansion of our CAG Diagnostics recurring revenues globally."ADNFCR-8000103-ID-801785654-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.